The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-4 of 4 articles
A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)
Garcia-Touchard A,
Goicolea J,
Sabaté M,
Alfonso F,
Ruiz-Salmeron R,
Bethencourt A,
Gonzalo N,
Miranda F,
García del Blanco B,
Jimenez Mazuecos J,
Melgares R,
Martinez-Romero P,
Hernandez-Garcia J,
Lezaun R,
Bullones J,
Fernandez Portales J,
Rumoroso J-R,
Ortas R,
Valdes M,
Trillo R,
Brugaletta S,
Otzuki S,
Hernández Pérez FJ,
Alonso-Pulpón L
January 20, 2017 | 10.4244/EIJ-D-16-00128
Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial
Fajadet J,
Neumann F,
Hildick-Smith D,
Petronio A,
Zaman A,
Spence M,
Wöhrle J,
Elhadad S,
Roberts D,
Hovasse T,
Valdes M,
Silber S
January 20, 2017 | 10.4244/EIJV12I13A262
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
Vlachojannis G,
Smits P,
Hofma S,
Togni M,
Vázquez N,
Valdes M,
Voudris V,
Puricel S,
Slagboom T,
Goy J-J,
den Heijer P,
van der Ent M
July 20, 2015 | 10.4244/EIJV11I3A53
A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial
Moreno R,
Garcia E,
Teles R,
Almeida M,
Carvalho H,
Sabaté M,
Martin-Reyes R,
Rumoroso J-R,
Galeote G,
Goicolea F,
Moreu J,
Mainar V,
Mauri J,
Ferreira R,
Valdes M,
Perez de Prado A,
Martin-Yuste V,
Jiménez-Valero S,
Sanchez Recalde A,
Calvo L,
de Sa E,
Macaya C,
López-Sendón J-L
May 25, 2010